206 related articles for article (PubMed ID: 10844714)
1. Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.
Beiser A; D'Agostino RB; Seshadri S; Sullivan LM; Wolf PA
Stat Med; 2000 Jun 15-30; 19(11-12):1495-522. PubMed ID: 10844714
[TBL] [Abstract][Full Text] [Related]
2. Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study.
Seshadri S; Wolf PA; Beiser A; Au R; McNulty K; White R; D'Agostino RB
Neurology; 1997 Dec; 49(6):1498-504. PubMed ID: 9409336
[TBL] [Abstract][Full Text] [Related]
3. A statistical analysis system macro for age-standardized incidence rates.
Immonen-Räihä P; Hätönen S; Torppa J; Toivanen A
Comput Methods Programs Biomed; 1994 Aug; 44(2):79-83. PubMed ID: 7988119
[TBL] [Abstract][Full Text] [Related]
4. Estimating lifetime and age-conditional probabilities of developing cancer.
Wun LM; Merrill RM; Feuer EJ
Lifetime Data Anal; 1998; 4(2):169-86. PubMed ID: 9658774
[TBL] [Abstract][Full Text] [Related]
5. Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease.
Brookmeyer R; Gray S
Stat Med; 2000 Jun 15-30; 19(11-12):1481-93. PubMed ID: 10844713
[TBL] [Abstract][Full Text] [Related]
6. The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study.
Cobb JL; Wolf PA; Au R; White R; D'Agostino RB
Neurology; 1995 Sep; 45(9):1707-12. PubMed ID: 7675231
[TBL] [Abstract][Full Text] [Related]
7. Assessing the risk of Alzheimer's disease in first-degree relatives of Alzheimer's disease cases.
Korten AE; Jorm AF; Henderson AS; Broe GA; Creasey H; McCusker E
Psychol Med; 1993 Nov; 23(4):915-23. PubMed ID: 8134515
[TBL] [Abstract][Full Text] [Related]
8. The lifetime risk of developing breast cancer.
Feuer EJ; Wun LM; Boring CC; Flanders WD; Timmel MJ; Tong T
J Natl Cancer Inst; 1993 Jun; 85(11):892-7. PubMed ID: 8492317
[TBL] [Abstract][Full Text] [Related]
9. Dementia and Alzheimer disease incidence: a prospective cohort study.
Kukull WA; Higdon R; Bowen JD; McCormick WC; Teri L; Schellenberg GD; van Belle G; Jolley L; Larson EB
Arch Neurol; 2002 Nov; 59(11):1737-46. PubMed ID: 12433261
[TBL] [Abstract][Full Text] [Related]
10. Estimating lifetime risk of developing high serum total cholesterol: adjustment for baseline prevalence and single-occasion measurements.
Pencina MJ; D'Agostino RB; Beiser AS; Cobain MR; Vasan RS
Am J Epidemiol; 2007 Feb; 165(4):464-72. PubMed ID: 17116649
[TBL] [Abstract][Full Text] [Related]
11. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study.
Bachman DL; Wolf PA; Linn RT; Knoefel JE; Cobb JL; Belanger AJ; White LR; D'Agostino RB
Neurology; 1993 Mar; 43(3 Pt 1):515-9. PubMed ID: 8450993
[TBL] [Abstract][Full Text] [Related]
12. PSHREG: a SAS macro for proportional and nonproportional subdistribution hazards regression.
Kohl M; Plischke M; Leffondré K; Heinze G
Comput Methods Programs Biomed; 2015 Feb; 118(2):218-33. PubMed ID: 25572709
[TBL] [Abstract][Full Text] [Related]
13. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
[TBL] [Abstract][Full Text] [Related]
14. Burden of Alzheimer's disease: population-based estimates and projections for New Zealand, 2006-2031.
Tobias M; Yeh LC; Johnson E
Aust N Z J Psychiatry; 2008 Sep; 42(9):828-36. PubMed ID: 18696288
[TBL] [Abstract][Full Text] [Related]
15. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
16. National estimates of the prevalence of Alzheimer's disease in the United States.
Brookmeyer R; Evans DA; Hebert L; Langa KM; Heeringa SG; Plassman BL; Kukull WA
Alzheimers Dement; 2011 Jan; 7(1):61-73. PubMed ID: 21255744
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.
Brookmeyer R; Gray S; Kawas C
Am J Public Health; 1998 Sep; 88(9):1337-42. PubMed ID: 9736873
[TBL] [Abstract][Full Text] [Related]
19. MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data.
De Angelis G; De Angelis R; Frova L; Verdecchia A
Comput Methods Programs Biomed; 1994 Aug; 44(2):99-107. PubMed ID: 7988122
[TBL] [Abstract][Full Text] [Related]
20. Risk of ESRD in the United States.
Albertus P; Morgenstern H; Robinson B; Saran R
Am J Kidney Dis; 2016 Dec; 68(6):862-872. PubMed ID: 27578184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
